Call for applications November 2017: Research grants

Research grants

The SFO announces up to four research grants for projects within the field of stem cells and regenerative medicine, one to two open to all candidates (senior grants) and two to three for candidates up to 12 years after their PhD (junior grants), counted until the day of the application deadline (time for parental leave, military service, and medical specialty training can be deducted). Priority will be given to high quality innovative projects.

Eligible projects will be supported for up to 2MSEK/year for 3 years. Grants can be used to cover salaries, running costs, equipment and administrative costs. Indirect costs for the research project must not exceed the INDI level at the receiving department. Starting date for grants is June 1st, 2018. However, within an active recruitment process, the starting date could be delayed to December 1st, 2018 at the latest. A researcher is limited to submit only one application for research grants or clinical research grants, i.e. not both.

Proposals will be evaluated and ranked by external international experts within the field. Final decisions will be taken by the SFO Steering committee.

Eligible to apply

For senior grants: Principal investigator. For junior grants: Principal investigators or researchers about to start an independent research group. PIs in the process of being recruited to KI and who will be employed at the latest December 1st, 2018 are also eligible, but will require a detailed letter of support by the chair of the receiving institution. A final decision about support will require that the applicant has started his or her employment at KI/SLL.  Grants will transferred to the KI department. Applicants should have a PhD degree and be affiliated 100% to KI and/or SLL at the time of starting the project. The proposed research program should have relevance for the field of stem cells and regenerative medicine. Applicants who received SFO Stem Cells and Regenerative Medicine research grants in 2017 are not eligible to apply.

Relevance

Stem cells play an important role in the development of tissues, for maintenance and regeneration of tissues in adulthood, and for development and progression of disease. Research in this field is rapidly expanding our understanding of these processes. Stem cell therapies are established in clinical medicine for malignant as well as for non-malignant conditions and novel therapies are continuously developed and entered in preclinical and clinical trials. Research projects with relevance for the above-described fields are eligible for support from this strategic research area.

Evaluation criteria and weights

Evaluation of quality and feasibility of the project 33%

5 = Outstanding

4 = Excellent

3 = Very good 

2 =Good

1 = Insufficient

 

Evaluation of the quality and merits of the scientist 33%. For junior applicants evaluation of the applicantĀ“s potential to start an independent and successful line of research

5 = Outstanding

4 = Excellent

3 = Very good 

2 = Good

1 = Insufficient

 

Evaluation of the originality of the project 33%

5 = Outstanding

4 = Excellent

3 = Very good 

2 = Good

1 = Insufficient

Application

Each application must be supported by the head of department, who will thereby ascertain that the applicant holds or will hold a 100% position at KI. If several departments are involved, each head of department should support the application.

  • Project description (6 pages, Times roman, 12 points, single space, 2 cm margin), covering: Summary (limit 200 words), Objectives, Introduction, Preliminary results, Experimental plan, Significance for the field and references.
  • CV, max 2 pages. Mark whether within 12 years from PhD.
  • List of publications, highlighting the 10 most relevant publications of the main applicant
  • Budget description

The application should be submitted in one pdf file to Sri Sahlin, Karolinska Institutet (Sri.Sahlin@ki.se)
Application deadline: January 15th, 2018
Decisions will be announced before May 1st, 2018